Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-11-24

Clinical Trial Update: Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors [NA]

View source ↗

Summary

A Stanford University study titled Cognitive Enhancement Program for Improving Cognitive Function in Breast Cancer Survivors has been withdrawn; no results or p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Breast Cancer, Cancer Survivor | NA | Status: WITHDRAWN